Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High molecular weight-melanoma-associated antigen as a biomarker of desmoplastic melanoma.

Literature DB >> 19968820

High molecular weight-melanoma-associated antigen as a biomarker of desmoplastic melanoma.

Yasufumi Goto, Takaaki Arigami, Rajmohan Murali, Richard A Scolyer, Atsushi Tanemura, Minoru Takata, Roderick R Turner, Linhda Nguyen, Tung Nguyen, Donald L Morton, Soldano Ferone, Dave S B Hoon.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2009 PMID： 19968820 PMCID： PMC2879036 DOI： 10.1111/j.1755-148X.2009.00660.x

Source DB: PubMed Journal: Pigment Cell Melanoma Res ISSN： 1755-1471 Impact factor: 4.693

× No keyword cloud information.

12 in total

1. Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma.

Authors: Timothy M Pawlik; Merrick I Ross; Victor G Prieto; Matthew T Ballo; Marcella M Johnson; Paul F Mansfield; Jeffrey E Lee; Janice N Cormier; Jeffrey E Gershenwald
Journal: Cancer Date: 2006-02-15 Impact factor: 6.860

2. Evaluation of sentinel lymph node status in spindle cell melanomas.

Authors: M C Thelmo; R W Sagebiel; P A Treseler; E T Morita; L H Nguyen; M Kashani-Sabet; S P Leong
Journal: J Am Acad Dermatol Date: 2001-03 Impact factor: 11.527

3. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.

Authors: S R Granter; K N Weilbaecher; C Quigley; C D Fletcher; D E Fisher
Journal: Am J Dermatopathol Date: 2001-06 Impact factor: 1.533

4. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.

Authors: M B Koch; I M Shih; S W Weiss; A L Folpe
Journal: Am J Surg Pathol Date: 2001-01 Impact factor: 6.394

5. Sentinel-node biopsy or nodal observation in melanoma.

Authors: Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Robert Elashoff; Richard Essner; Omgo E Nieweg; Daniel F Roses; Harald J Hoekstra; Constantine P Karakousis; Douglas S Reintgen; Brendon J Coventry; Edwin C Glass; He-Jing Wang
Journal: N Engl J Med Date: 2006-09-28 Impact factor: 91.245

6. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma.

Authors: K J Busam; K Iversen; K C Coplan; A A Jungbluth
Journal: Am J Surg Pathol Date: 2001-02 Impact factor: 6.394

7. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study.

Authors: T A Longacre; B M Egbert; R V Rouse
Journal: Am J Surg Pathol Date: 1996-12 Impact factor: 6.394

8. Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma.

Authors: David E Gyorki; Klaus Busam; Kathy Panageas; Mary Sue Brady; Daniel G Coit
Journal: Ann Surg Oncol Date: 2003-05 Impact factor: 5.344

Review 9. Desmoplastic melanoma: a diagnostic trap for the unwary.

Authors: Stanley W McCarthy; Richard A Scolyer; A Allan Palmer
Journal: Pathology Date: 2004-10 Impact factor: 5.306

10. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients.

Authors: M J Quinn; K A Crotty; J F Thompson; A S Coates; C J O'Brien; W H McCarthy
Journal: Cancer Date: 1998-09-15 Impact factor: 6.860

7 in total

Review 1. Progression of cutaneous melanoma: implications for treatment.

Authors: Stanley P L Leong; Martin C Mihm; George F Murphy; Dave S B Hoon; Mohammed Kashani-Sabet; Sanjiv S Agarwala; Jonathan S Zager; Axel Hauschild; Vernon K Sondak; Valerie Guild; John M Kirkwood
Journal: Clin Exp Metastasis Date: 2012-08-15 Impact factor: 5.150

High molecular weight-melanoma-associated antigen as a biomarker of desmoplastic melanoma.

1. Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma.

2. Evaluation of sentinel lymph node status in spindle cell melanomas.

3. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.

4. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.

5. Sentinel-node biopsy or nodal observation in melanoma.

6. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma.

7. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study.

8. Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma.

Review 9. Desmoplastic melanoma: a diagnostic trap for the unwary.

10. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients.

Review 1. Progression of cutaneous melanoma: implications for treatment.

Review 2. Prognostic molecular biomarkers for cutaneous malignant melanoma.

Review 3. Diagnostic and prognostic biomarkers in melanoma.

Review 4. Emerging Biomarkers in Cutaneous Melanoma.

5. [Molecular diagnostics for monitoring and predicting therapeutic effect in cancer].

Review 6. Melanoma biomolecules: independently identified but functionally intertwined.

Review 7. Theranostic impact of NG2/CSPG4 proteoglycan in cancer.